Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the highest quintile among peers.
BNY Mellon International Equity C NIECX
- NAV / 1-Day Return 21.06 / +1.10 %
- Total Assets 310.6 Mil
-
Adj. Expense Ratio
- Expense Ratio 1.820%
- Distribution Fee Level Below Average
- Share Class Type Level Load
- Category Foreign Large Blend
- Investment Style Large Growth
- Min. Initial Investment 1,000
- Status Closed
- TTM Yield 0.89%
- Turnover 46%
USD | NAV as of Apr 26, 2024 | 1-Day Return as of Apr 26, 2024, 10:18 PM GMT+0
Morningstar’s Analysis NIECX
Will NIECX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 28.4
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
ASML Holding NV | 3.95 | 12.8 Mil | Technology |
Nestle SA | 3.43 | 11.1 Mil | Consumer Defensive |
Novo Nordisk A/S Class B | 3.31 | 10.7 Mil | Healthcare |
Lvmh Moet Hennessy Louis Vuitton SE | 3.03 | 9.8 Mil | Consumer Cyclical |
SAP SE | 2.66 | 8.6 Mil | Technology |
Novartis AG Registered Shares | 2.63 | 8.5 Mil | Healthcare |
AstraZeneca PLC | 2.57 | 8.3 Mil | Healthcare |
Air Liquide SA | 2.27 | 7.3 Mil | Basic Materials |
Wolters Kluwer NV | 2.26 | 7.3 Mil | Industrials |
Sanofi SA | 2.23 | 7.2 Mil | Healthcare |